Regulations.gov document
Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary…
Other · FDA-2009-D-0568 · posted Oct 31, 2022
Key facts
| Document ID | FDA-2009-D-0568-0013 |
|---|---|
| Title | Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products; Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2009-D-0568 |
| Posted | Oct 31, 2022 |
| Comment period opens | Oct 31, 2022 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: